For the year ending 2026-03-28, HAE has $2,395,925K in assets. $245,440K in cash and cash equivalents.
| Balance Sheets | 2026-03-28 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 245,440 | |||
| Accounts receivable, less allowance for credit losses of 3,693 as of march28, 2026 and 6,300 as of march29, 2025 | 216,855 | |||
| Inventories, net | 306,370 | |||
| Prepaid expenses and other current assets | 66,214 | |||
| Total current assets | 834,879 | |||
| Property, plant and equipment, net | 305,761 | |||
| Intangible assets, less accumulated amortization of 363,763 as of march28, 2026 and 316,313 as of march29, 2025 | 447,655 | |||
| Goodwill | 656,368 | |||
| Deferred tax asset | 9,521 | |||
| Other long-term assets | 141,741 | |||
| Total assets | 2,395,925 | |||
| Notes payable and current maturities of long-term debt | 5,015 | |||
| Accounts payable | 51,056 | |||
| Accrued payroll and related costs | 68,191 | |||
| Other current liabilities | 158,337 | |||
| Total current liabilities | 282,599 | |||
| Long-term debt, net of current maturities | 1,219,565 | |||
| Deferred tax liability | 38,048 | |||
| Other long-term liabilities | 59,393 | |||
| Common stock, 0.01par value authorized 150,000,000shares issued and outstanding 45,252,667shares as of march28, 2026 and 48,215,899shares as of march29, 2025 | 453 | |||
| Additional paid-in capital | 554,137 | |||
| Retained earnings | 279,344 | |||
| Accumulated other comprehensive loss | -37,614 | |||
| Total stockholders equity | 796,320 | |||
| Total liabilities and stockholders equity | 2,395,925 | |||
HAEMONETICS CORP (HAE)
HAEMONETICS CORP (HAE)